Agios Pharmaceuticals, Inc. (AGIO)
31.80
-0.68
(-2.09%)
USD |
NASDAQ |
Oct 02, 16:00
31.82
+0.02
(+0.06%)
After-Hours: 20:00
Agios Pharmaceuticals Market Cap : 1.895B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.895B |
| October 01, 2026 | 1.936B |
| September 30, 2026 | 1.982B |
| September 29, 2026 | 1.985B |
| September 28, 2026 | 1.992B |
| September 25, 2026 | 1.942B |
| September 24, 2026 | 1.961B |
| September 23, 2026 | 2.038B |
| September 22, 2026 | 2.084B |
| September 21, 2026 | 2.024B |
| September 18, 2026 | 1.971B |
| September 17, 2026 | 2.003B |
| September 16, 2026 | 1.964B |
| September 15, 2026 | 1.956B |
| September 14, 2026 | 1.980B |
| September 11, 2026 | 2.003B |
| September 10, 2026 | 2.005B |
| September 09, 2026 | 2.064B |
| September 08, 2026 | 2.000B |
| September 04, 2026 | 1.973B |
| September 03, 2026 | 1.975B |
| September 02, 2026 | 2.034B |
| September 01, 2026 | 2.039B |
| August 31, 2026 | 2.007B |
| August 28, 2026 | 1.986B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.043B |
| August 26, 2026 | 2.026B |
| August 25, 2026 | 2.021B |
| August 24, 2026 | 1.946B |
| August 21, 2026 | 1.972B |
| August 20, 2026 | 2.005B |
| August 19, 2026 | 2.093B |
| August 18, 2026 | 2.050B |
| August 17, 2026 | 2.005B |
| August 14, 2026 | 2.000B |
| August 13, 2026 | 1.995B |
| August 12, 2026 | 2.039B |
| August 11, 2026 | 1.948B |
| August 10, 2026 | 1.943B |
| August 07, 2026 | 1.923B |
| August 06, 2026 | 1.904B |
| August 05, 2026 | 1.891B |
| August 04, 2026 | 1.884B |
| August 03, 2026 | 1.820B |
| July 31, 2026 | 1.789B |
| July 30, 2026 | 1.952B |
| July 29, 2026 | 2.087B |
| July 28, 2026 | 2.145B |
| July 27, 2026 | 2.204B |
| July 24, 2026 | 2.158B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Biogen, Inc. | 32.48B |
| Insmed, Inc. | 24.26B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Regeneron Pharmaceuticals, Inc. | 76.02B |
Market Cap Related Metrics
| PS Ratio | 18.98 |
| Price to Book Value | 1.847 |
| Price | 31.80 |
| Earnings Yield | -22.04% |